Phenotyping coding variants in cancer using Perturb-seq
Oana Ursu, 1 February 2022
Oana is a postdoc working with Prof. Aviv Regev at Genentech. She studies the molecular basis of cellular decisions and resulting cell states using pooled high-content screening, applied to profile the impact of coding variation in cancer (collaboration with JT Neal, Jesse Boehm at the Broad Institute).
EVENT FLYER for Phenotyping coding variants in cancer using Perturb-seq
WATCH RECORDING of Phenotyping coding variants in cancer using Perturb-seq
